Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic

The significant morbidity and mortality of coronavirus disease 19 (COVID-19) prompted a global race to develop new therapies. These include interventions using cell- or cell-derived products, several of which are being tested in well-designed, properly controlled clinical trials. Yet, the search for...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Leigh, Munsie, Megan, Levine, Aaron D., Ikonomou, Laertis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516140/
https://www.ncbi.nlm.nih.gov/pubmed/34653406
http://dx.doi.org/10.1016/j.stemcr.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516140/
https://www.ncbi.nlm.nih.gov/pubmed/34653406
http://dx.doi.org/10.1016/j.stemcr.2021.09.005

Ejemplares similares